Time to Buy U.S. Pot Stocks

Jeff Siegel

Written By Jeff Siegel

Posted November 1, 2018

We all knew it was going to happen.

Well, at least those of us who paid attention.

The huge run on Canadian cannabis stocks did, in fact, come to an end just as legalization kicked in.

Of course, it didn’t take a rocket scientist to figure this one out.

You know the drill…

Buy the rumor, sell the news.

And that’s exactly what we did.

The result?

Members of my Green Chip Stocks community just bagged the following gains:

  • Aphria, Inc. (TSX: APH) — 1,174.3%
  • OrganiGram Holdings (TSX-V: OGI) — 1,185%
  • Emblem Corp. (TSX-V: EMC) — 152%
  • Emerald Health Therapeutics (TSX-V: EMH) — 151.85%
  • RavenQuest BioMed (CSE: RQB) — 103.7%
  • Canopy Growth Corporation (TSX: WEED) — 3,105%

To put that last one in perspective, a one-time investment of just $32K turned into a cool $1 million.

That’s what I like to call a “Millionaire-Maker.”

And there’s more to come.

It’s just that our next round of cannabis stock profits won’t be coming from Canada. They’ll be coming from the U.S.

Under the Radar

If you’re a regular reader of these pages, you know we’re now quite bullish on a handful of quality U.S. cannabis stocks: MariMed Advisors (OTCBB: MRMD), Liberty Health Sciences (OTCBB: LHSIF), and iAnthus Holdings (OTCBB: ITHUF), just to name a few.

In addition to those, which are already quite well known in the space, we’re also seeking out some of the lesser-known U.S. players that, while they may not be common names on Wall Street yet, are quite valuable.

One in particular is a company called Halo Labs (NEO: HALO).

Halo Labs is an Oregon-based manufacturer of cannabis oils and concentrates that boasts more than 20% of the Oregon concentrates wholesale market.

Since inception, the company has sold more than 2 million grams and currently ships about 90,000 grams per month. It has a 16,000-square-foot manufacturing facility in Medford, Oregon, seven acres of outdoor capacity in Jackson County, and a 25-month operating history. In other words, Halo isn’t new to the game and has generated significant revenue over the past two years, with 2016 revenues coming in at $3.8 million and 2017 revenues coming in at $10.3 million. About 35% of Halo’s revenues come from white label sales, which is expected to grow to 50% by next year.

But Oregon is just the beginning.

Halo also has a 12,000-square-foot licensed facility in Las Vegas with a material supply agreement already in place. This is actually a pretty big deal considering that Nevada processing licenses are extremely limited. This, of course, is great for Halo, as it’s now entering a market that currently has a shortage of clean concentrates and oils. This shortage won’t last forever, but it will likely bleed into 2019.

Halo also has a 5,000-square-foot licensed facility in Southern California with conditional use permits and temporary state licenses issued. At full capacity, it can produce 10,000 grams per day. The potential run-rate revenue at this location is $30MM annually. This facility is expected to be online next month.

Halo is also in discussions to set up shop in Florida, Massachusetts, Colorado, and Virginia.

Bottom line: This is an established player in the concentrates and oils space, and it’s in the U.S., generating more than $10 million in revenue.

Now, the company just recently went public, and for the sake of full disclosure, management recently spoke at a private Green Chip Stocks event that was held in Midtown Manhattan just one week ago. It’s there that members of our investment community had the opportunity to not only listen to the company’s CEO present to our group but actually network with him and his team. As well, all were invited to a private brunch the next day to continue the networking.

This, by the way, was all free of charge for our members. It’s just one of the many perks to a Green Chip Stocks membership.

Of course, while private, high-end meetings with the most successful cannabis companies on the planet are certainly a highlight of our membership, the real advantage all boils down to our gains.

Just as I was able to deliver gains in excess of 1,000% for our members who took my early advice on buying Canadian cannabis stocks, I’m about to do the same again for those who take my early advice on buying a select group of U.S. cannabis stocks that are set deliver those same triple- and quadruple-digit gains.

You can get access to this list of stocks by clicking here.

Or, if you just want to learn more about my strategy for landing 1,000% gains in the cannabis market, you can check out this detailed strategy outline, which is available for free download.

Make no mistake: While we made a fortune in the Canadian cannabis space, what we’re going to pull in from the U.S. cannabis space will make those gains look like chump change.

So if you want a piece of this action, too, click here now.

To a new way of life and a new generation of wealth…

Jeff Siegel Signature

Jeff Siegel

follow basicCheck us out on YouTube!

follow basic@JeffSiegel on Twitter

Jeff is the founder and managing editor of Green Chip Stocks. For more on Jeff, go to his editor’s page.

Want to hear more from Jeff? Sign up to receive emails directly from him ranging from market commentaries to opportunities that he has his eye on. 

Angel Publishing Investor Club Discord - Chat Now

Jeff Siegel Premium

Introductory

Hydrogen Fuel Cells: The Downfall of Tesla?

Lithium has been the front-runner in the battery technology market for years, but that is all coming to an end. Elon Musk is against them, but Jeff Bezos is investing heavily in them. Hydrogen Fuel Cells will turn the battery market upside down and we've discovered a tiny company that is going to make it happen...

Sign up to receive your free report. After signing up, you'll begin receiving the Energy and Capital e-letter daily.